Abstract
Purpose
To evaluate long-term outcome in nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy.
Methods
Between January 2006 and August 2008, 300 patients with histologically proven NPC were enrolled in this multicenter prospective study. All patients received definitive IMRT. Cisplatin-based concurrent chemotherapy was given to patients with stages III-IVb disease.
Results
Median follow-up time was 47.1 months (range 11–68 months). Median survival time was not reached. For all patients, the 4-year local control (LC), regional control (RC), distant metastasis-free survival (DMFS), and overall survival (OS) were 94.0, 95.1, 85.0, and 86.1 %, respectively. Thirty-five patients experienced locoregional failures: 18 were local only, 15 were regional only, and 2 were both local and regional. Forty-two patients developed distant metastasis. Of these, 32 patients had single organ metastasis, and 10 patients had multiple organ metastasis. The most common acute toxicities were mucositis, dermatitis, and xerostomia. Grade 0–2 mucositis, dermatitis, and xerostomia occurred in 200 patients (66.7 %), 288 patients (96.0 %), and 286 patients (95.3 %), respectively. Grade 3 mucositis, dermatitis, and xerostomia were seen in 100 patients (33.3 %), 12 patients (4.0 %), and 14 patients (4.7 %), respectively. No Grade 4 acute toxicities were observed. The most common late toxicity for 284 patients who survived for more than 2 years was xerostomia. At 3 months after treatment, 16.2 % of patients had Grade 1, 73.6 % had Grade 2, and 10.2 % had Grade 3 xerostomia. However, the severity of xerostomia decreased over time. At 24 months, only 12.3 % of patients had Grade 2 xerostomia, and none had Grade 3 or 4 xerostomia.
Conclusions
IMRT for NPC patients achieved excellent long-term locoregional control (LRC) and OS, with acceptable acute and late toxicities. After the treatment, xerostomia was improved over time. Distant metastasis remained the main cause of failure. More effective systemic therapy is demanding for reducing the risk of distant metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheng JC, Chao KS, Low D (2001) Comparison of intensity-modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96:126–131
Han L, Lin S, Pan J et al (2010) Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer 29:145–150
Kam MK, Chau RM, Suen J et al (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56:145–157
Kam MK, Leung SF, Zee B et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early stage nasopharyngeal carcinoma. J Clin Oncol 25:4873–4879
Kwong DL, Pow EH, Sham JS et al (2004) Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101:1584–1593
Kwong DL, Sham JS, Leung LH et al (2006) Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64:374–381
Lai SZ, Li WF, Chen L et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80:661–668
Lee N, Xia P, Quivey JM et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12–22
Lee SW, Back GM, Yi BY et al (2006) Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65:152–160
Lee N, Harris J, Garden AS et al (2009) Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 27:3684–3690
Lin S, Pan J, Han L et al (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75:1071–1078
Lu H, Peng L, Yuan X et al (2009) Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev 35:345–353
Ng WT, Lee MCH, Hung WM et al (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79:420–428
Pow EH, Kwong DL, McMillan AS et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66:981–991
Teo PM, Ma BB, Chan AT (2004) Radiation therapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional method. Radiother Oncol 73:163–172
Toledano I, Graff P, Serre A et al (2012) Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004–03. Radiother Oncol 103:57–62
Wang J, Shi M, Hsia Y et al (2012) Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation in Northwest China: a pilot study. Radiat Oncol 7:2
Wu S, Xie CY, Jin X et al (2006) Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal carcinoma; a local center’s experience. Int J Radiat Oncol Biol Phys 66:S40–S46
Xia P, Fu KK, Wong GW et al (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48:329–337
Zhao C, Lu L, Han F et al (2005) Preliminary results of intensity-modulated radiation therapy alone for 122 patients with untreated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 63:S382
Acknowledgments
This work was supported by the Sci-Tech Office of Guangxi Zhuang Autonomous Region (0632007-2F) and the Key Research Program of Guangxi Health Department (200527).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
R. Wang, F. Wu, and H. Lu authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, R., Wu, F., Lu, H. et al. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study. J Cancer Res Clin Oncol 139, 139–145 (2013). https://doi.org/10.1007/s00432-012-1313-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-012-1313-0